Phaarmasia Limited (BSE: 523620)
Health Care · Pharmaceuticals · IN
Rs92.00
-0.43% today · +194.7% 1Y
Phaarmasia Limited (BSE: 523620) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.49M.
Over the last twelve months the share price has gained 194.7%, trading between 30.01 and 131.75.
Tweenvest scores Phaarmasia Limited across four factors: quality 64/100, value 49/100, growth 65/100. Its strongest factor is growth.
523620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.49M
- Revenue (TTM)
- $5.14M
- P/E
- 3.56
- EPS
- 25.82
- Dividend yield
- —
- Beta (5Y)
- 0.79
- 52-week high
- Rs131.75
- 52-week low
- Rs30.01
- Avg volume (3M)
- —
- Shares outstanding
- 6.83M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PreveCeutical Medical Inc.CNSX: PREV | $6.71M | CA$0.02 | -25.00% |
| Cian Healthcare LimitedBSE: 542678 | $6.70M | Rs25.95 | +6.00% |
| Reviva Pharmaceuticals Holdings, Inc.OTCPK: RVPH | $6.56M | $0.50 | +1.02% |
| Enveric Biosciences, Inc.NasdaqCM: ENVB | $6.49M | $1.45 | -2.03% |
| Numinus Wellness Inc.OTCPK: NUMI.F | $6.46M | $0.02 | -9.23% |
| Light AI Inc.DB: 0HC | $6.44M | €0.06 | -28.24% |
| Vivimed Labs LimitedNSEI: VIVIMEDLAB | $6.21M | Rs7.25 | +26.97% |
| Phong Phu Pharmaceutical Joint Stock CompanyHNX: PPP | $6.16M | ₫— | — |
Figures last refreshed Oct 11, 2026.